Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06534554 · ClinicalTrials.gov registry record · NA

Improving Gout Care After an ED Visit

A NA study of Gout, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06534554 is a NA study of Gout that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants, below the 8,882-participant average among 34 other Gout trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06534554, a NA study of Gout, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The prevalence of gout has been steadily increasing over several decades and is correlated with the rising burden of obesity, chronic cardiac and renal disease; all conditions overrepresented in the Southeastern U.S. - particularly in African Americans. Through a novel post-emergency department visit intervention, we aim to improve the care patients with gout receive, both during acute exacerbations and long-term. A secondary goal of the project is to concurrently enhance participation of minorities in biomedical research in the Deep South.

Conditions Studied

Interventions

  • BEHAVIORAL Patient Navigation

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-06-18
Est. Completion 2027-06-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06534554

The ClinicalTrials.gov registry entry for NCT06534554 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,882-participant average among 34 other Gout trials with a reported enrollment target (98% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gout appearing as the primary indexed condition, and to 1 intervention - of which Patient Navigation is the first listed.

NCT06534554 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06534554 about?

NCT06534554 is a clinical study titled "Improving Gout Care After an ED Visit". The prevalence of gout has been steadily increasing over several decades and is correlated with the rising burden of obesity, chronic cardiac and renal disease; all conditions overrepresented in the Southeastern U.S. - particularly in African Americans. Through a novel post-emergency department visi...

What is the current status of trial NCT06534554?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-18. Estimated completion is 2027-06-01.

What conditions does trial NCT06534554 study?

This clinical trial studies the following conditions: Gout.

What interventions are being tested in trial NCT06534554?

The interventions under investigation include: Patient Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06534554?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06534554 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gout

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.